HIGHLIGHTS
- who: Filipa Amaro et al. from the University of, National Food Institute, Technical University of Denmark, Kongens Lyngby, Copenhagen, Denmark have published the Article: Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety, in the Journal: (JOURNAL)
- what: This study reports, for the first time to the knowledge , the impact of clinically relevant concentrations of sunitinib and pazopanib in the metabolic profiles of a metastatic RCC cell line (Caki-1) and a non-tumorigenic renal cell line (HK-2). In agreement with this study, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.